Tag John Y.M. Koo

Trichotillomania

Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Open full size image Trichotillomania, or hair-pulling disorder, is the impulsive, repetitive action of…

Psychogenic excoriation

Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Open full size image Psychogenic excoriation is a psychodermatologic condition in which patients participate…

Dermatitis artefacta

Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Open full size image Dermatitis artefacta (DA), also known as factitious dermatitis , is…

Delusions of parasitosis

Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Open full size image Delusions of parasitosis (DOP) is a form of delusional disorder,…

Psychocutaneous Diseases

Key Points 1. Up to 40% of all dermatologic patients have an associated psychiatric comorbidity. 2. Patients with cutaneous dysesthesia can present with many different complaints, but treatment is based on whether the symptoms are primarily pruritic or primarily painful.…

Psychocutaneous Diseases

Introduction “Psychodermatology” refers to any aspect of dermatology in which psychological factors play a significant role. At least a third of patients seen in dermatology practices require consideration of associated emotional and psychosocial factors for effective management of their skin…

Psychotropic Agents

Questions Q35.1 What are the four main categories of psychodermatologic disorders? (Pg. 383, Fig. 35.1 ) Q35.2 What are the four major underlying psychopathologic conditions upon which the medication choice is decided (what is the ‘fifth’ nonpsychiatric category of interest)?…

Cyclosporine

Questions Q17.1 What are the differences between the Sandimmune and Neoral versions of cyclosporine (CsA) in their (1) formulation, (2) bioavailability, and (3) consistency of absorption? (Pgs. 187, 188, 195) Q17.2 Regarding the mechanism of action for CsA, what is…